3,5-diiodothyropropionic acid clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How each study uses 3,5-diiodothyropropionic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- DITPA
- 1
Studies by the year they started
3 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
US Department of Veterans Affairs (1) · Johns Hopkins University (1) · Titan Pharmaceuticals (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses 3,5-diiodothyropropionic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)TerminatedPhase 2US Department of Veterans AffairsNCT00032643Written as DITPA
- Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic PatientsTerminatedPhase 1/2Johns Hopkins UniversityNCT00311987Written as 3,5-Diiodothyropropionic acid (DITPA) therapy
- Study of DITPA in Patients With Congestive Heart FailureTerminatedPhase 2Titan PharmaceuticalsNCT00103519Written as DITPA (3,5-diiodothyropropionic acid)
Codes
What other systems call 3,5-diiodothyropropionic acid · ClinicalTrials.gg INT003740
- MeSH (NLM) C0821823,5-diiodothyropropionic acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1HTO2X0SJ93,5-DIIODOTHYROPROPIONIC ACIDConfirmed NLM, Wikidata
- Wikidata Q272524333,5-diiodothyropropionic acidConfirmed NLM, Wikidata
- DrugBank DB12629One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C082182 | 3,5-diiodothyropropionic acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1HTO2X0SJ9 | 3,5-DIIODOTHYROPROPIONIC ACID | Confirmed NLM, Wikidata |
| Wikidata | Q27252433 | 3,5-diiodothyropropionic acid | Confirmed NLM, Wikidata |
| DrugBank | DB12629 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.